Effective as of September 27, 2021, David Pernock was appointed as Executive Vice President, Operations of Eagle Pharmaceuticals, Inc., or the Company. He previously served as President and Chief Operating Officer of the Company since January 2017. On September 27, 2021, the Board of Directors, or the Board, appointed Scott Tarriff as President, effective immediately. In addition to his role as President, Mr. Tarriff will continue to serve as Chief Executive Officer. On September 27, 2021, the Board appointed Michael Moran as the Company's Executive Vice President, Chief Commercial Officer, effective immediately, in which position he will serve as the Company's principal operating officer. Mr. Moran, age 53, joined the Company in January 2016 as Vice President, Sales and was promoted to Executive Vice President, Sales, Business Development and Government Affairs in August 2019.